Elevance Health, Inc.

Equities

ELV

US0367521038

Managed Healthcare

Market Closed - Nyse 16:00:02 2024-07-17 EDT 5-day change 1st Jan Change
520.9 USD -5.82% Intraday chart for Elevance Health, Inc. -2.56% +10.47%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Dow Closes at Record, Nasdaq Slides as Markets Parse Fed Governor Remarks, Earnings MT
Dow Closes at Record High as Nasdaq Plunges; Markets Parse Fed Governor Remarks, Earnings, Trade Threats MT
Sector Update: Health Care Stocks Advance Late Afternoon MT
Fed Governor's Remarks, Earnings Leave Equities Mixed MT
Sector Update: Health Care Stocks Higher Wednesday Afternoon MT
Fed Governor Waller's Comments, Earnings Leave Equities Mixed; Nvidia Slides MT
Global markets live: Adidas, TSMC, Vale, HSBC, J&J... Our Logo
Top Midday Stories: Chip Stocks Fall; MBA US Mortgage Applications Rebound; Johnson & Johnson, Elevance Health Q2 Earnings Rise; Prologis Posts Q2 Beat; VF to Sell Supreme Brand to EssilorLuxottica MT
Elevance Health Quarterly Results Top Views; Maintains Full-Year Earnings Outlook MT
Stocks in motion: VF Corp and Johnson & Johnson stand out Our Logo
Sector Update: Health Care Stocks Lean Lower Premarket Wednesday MT
Transcript : Elevance Health, Inc., Q2 2024 Earnings Call, Jul 17, 2024
Stock Futures Decline as Traders Await More Earnings; Asia, Europe Churn MT
Elevance Health's Q2 Adjusted Earnings, Revenue Increase MT
Elevance beats profit estimates on lower-than-expected medical costs RE
Earnings Flash (ELV) ELEVANCE HEALTH Posts Q2 Revenue $43.22B, vs. Street Est of $42.90B MT
Elevance Health, Inc. Declares Dividend for the Third Quarter of 2024, Payable on September 25, 2024 CI
Earnings Flash (ELV) ELEVANCE HEALTH Posts Q2 EPS $10.12, vs. Street Est of $10.01 MT
Elevance Health beats quarterly profit estimates RE
Elevance Health, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024 CI
Truist Securities Adjusts Price Target on Elevance Health to $620 From $600, Maintains Buy Rating MT
50 billion dollars - What US insurers pocketed for fictitious illnesses Our Logo
Elevance Health, Inc.(NYSE:ELV) dropped from Russell 1000 Dynamic Index CI
Investors need more time to assess Fed comments Our Logo
CMS to rework quality ratings for Medicare Advantage plans RE
Chart Elevance Health, Inc.
More charts
Elevance Health, Inc. is the American leading of health insurance. The group provides a broad range of medical and specialty products and services (life and disability insurance, medication, dental, vision insurance system and behavioral care insurance system, long-term health care insurance, medical expenses management, etc.). Elevance Health, Inc. is an independent licensee of the Blue Cross and Blue Shield Association, an independent association providing health insurance system. At the end of 2023, the group had nearly 47 million medical members.
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
23
Last Close Price
553.1 USD
Average target price
611.5 USD
Spread / Average Target
+10.55%
Consensus
  1. Stock Market
  2. Equities
  3. ELV Stock
  4. News Elevance Health, Inc.
  5. Fed Governor's Remarks, Earnings Leave Equities Mixed